In the last six months Colorado, Louisiana, Missouri, Michigan and, most recently, Arizona have passed “right to try” laws that allow terminally ill patients to access treatments that have only passed…
Articles on Drug approval
Displaying 21 - 24 of 24 articles
On November 4, the state of Arizona will decide whether to join Colorado, Missouri, Louisiana and Michigan in passing so-called right to try laws. If passed, the “Arizona Terminal Patients’ Right To Try…
Developing new drugs is hard and expensive. The lengthy process from initial discovery to the market is some times compared to the difficulty of putting a person on the moon. Despite accusations that the…
Between 2005 and 2011, nearly half of all new drug formulations in the US were approved without companies having to demonstrate a tangible benefit, such as relieving disease symptoms, extending life, or…
Top contributors
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Assistant Professor, Dalla Lana School of Public Health & Joint Centre for Bioethics, University of Toronto
-
Professor of Law and Public Health, The Ohio State University
-
Assistant Professor of Oncology at the School of Medicine, Johns Hopkins University
-
Clinician-Scientist, St. Michael’s Hospital; Associate Professor, Faculty of Medicine, University of Toronto
-
Ontario Research Chair in Bioethics and Public Policy, Queen's University, Ontario
-
Professor, Health Sciences, Simon Fraser University
-
Professor, Department of Geography, Simon Fraser University
-
Director of the Health Justice Institute at the Schulich School of Law, Dalhousie University
-
Lecturer in Pharmacology, Lancaster University
-
Professor of Economics, University of Calgary
-
Professor of Law, Wake Forest University
-
Associate Professor, School of Public Health, University of Alberta
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
PhD, School of Nursing, Dalhousie University